Editorial: The regulatory immune system as a target to improve adjuvants and novel vaccines

Carlos Jiménez-Cortegana; Cristina Poveda; Gabriel Cabrera

doi:10.3389/fcimb.2023.1223689

Editorial: The regulatory immune system as a target to improve adjuvants and novel vaccines

Front Cell Infect Microbiol. 2023 Jun 5:13:1223689. doi: 10.3389/fcimb.2023.1223689. eCollection 2023.

Authors

Carlos Jiménez-Cortegana¹, Cristina Poveda², Gabriel Cabrera³

Affiliations

¹ Department of Medical Biochemistry, Molecular Biology and Immunology, Faculty of Medicine, University of Seville, Seville, Spain.
² Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.
³ Laboratorio de Tecnología Inmunológica, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe Capital, Argentina.

No abstract available

Keywords: FOXP3+ regulatory T cells; MDSCs; Tregs; cancer; myeloid-derived suppressor cells; pathogens; vaccination; vaccine.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Adjuvants, Immunologic / pharmacology
Immune System
Vaccines*

Substances

Vaccines
Adjuvants, Immunologic

Grants and funding

This work was supported by ANPCyT (Argentine National Agency for the Promotion of Science and Technology) (PICT 2018-01164 and PICT 2019-01948), CONICET (National Scientific and Technical Research Council) and the Universidad Nacional del Litoral, Argentina. CJ-C is supported by a Margarita Salas fellowship, granted by the University of Seville (Seville, Spain)